about
Opaque cells signal white cells to form biofilms in Candida albicansReal-time microscopic observation of Candida biofilm development and effects due to micafungin and fluconazole.Development of a 96-well catheter-based microdilution method to test antifungal susceptibility of Candida biofilmsShear stress modulates the thickness and architecture of Candida albicans biofilms in a phase-dependent mannerPatients with long-term oral carriage harbor high-persister mutants of Candida albicansNovel high-throughput screen against Candida albicans identifies antifungal potentiators and agents effective against biofilms.A murine model of contact lens-associated fusarium keratitis.A quantitative real-time RT-PCR assay for mature C. albicans biofilms.Hydrophobicity and helicity regulate the antifungal activity of 14-helical β-peptides.Vascular catheter-associated infections: a microbiological and therapeutic update.Dodonaea viscosa var. angustifolia Inhibits Germ Tube and Biofilm Formation by C. albicans.Confocal analysis of the exopolysaccharide matrix of Candida albicans biofilms.Biofilm formation by and antifungal susceptibility of Candida isolates from urine.Role for cell density in antifungal drug resistance in Candida albicans biofilmsEap1p, an adhesin that mediates Candida albicans biofilm formation in vitro and in vivo.Lipidomics of Candida albicans biofilms reveals phase-dependent production of phospholipid molecular classes and role for lipid rafts in biofilm formationFungal Biofilms: In Vivo Models for Discovery of Anti-Biofilm DrugsBiofilm production by Candida: comparison of bloodstream isolates with cervical isolates.Life within a community: benefit to yeast long-term survival.Candida albicans cell wall proteinsCandida albicans: A Model Organism for Studying Fungal Pathogens.Host defense at the ocular surfaceMicafungin for the prophylaxis and treatment of Candida infections.Efflux-mediated antifungal drug resistance.Ras signaling gets fine-tuned: regulation of multiple pathogenic traits of Candida albicans.Development of Candida-associated denture stomatitis: new insightsMolecular and cellular mechanisms that lead to Candida biofilm formation.Gene Ontology and the annotation of pathogen genomes: the case of Candida albicans.Our current understanding of fungal biofilms.Fungal Biofilms: Relevance in the Setting of Human Disease.Cryptococcosis: epidemiology, fungal resistance, and new alternatives for treatment.Plasma membrane lipids and their role in fungal virulence.Fungal biofilm composition and opportunities in drug discovery.Candida albicans biofilms produce antifungal-tolerant persister cells.Interaction of Candida albicans biofilms with antifungals: transcriptional response and binding of antifungals to beta-glucans.Antifungal activity of a β-peptide in synthetic urine media: Toward materials-based approaches to reducing catheter-associated urinary tract fungal infections.Efficacy of citronella and cinnamon essential oils on Candida albicans biofilms.Prevalence of oral Candida in the first year of life.Does removal of CU-IUD in patients with biofilm forming candida really maintain regression of clinical symptoms?Differential activities of newer antifungal agents against Candida albicans and Candida parapsilosis biofilms
P2860
Q24544014-29AA7B6B-696B-4499-AC5D-603CC00B15EBQ30539101-05148C1C-CE70-400E-BF8B-867490F72970Q31032056-321C372F-F3D7-4D22-B276-3D59869324E9Q33392309-D0381D08-1DD6-4827-ADDB-E1F13000E747Q33558990-1ECE544F-ACB3-40C7-9C3C-9C85416089DAQ33843060-0FBC8B04-929E-4CCF-B274-D65C1136E901Q33845177-011C78A5-8B97-4FA1-AE00-76B0590DD7BDQ33891605-42E3D115-5F2C-4C0C-A74A-7C6F1BF56A5CQ33926906-B9324026-24B4-4D9A-9FE5-DF3AD493542DQ34585059-6BA140AF-2CD0-497C-902F-54F8ABB76D6FQ35040576-3B502C5A-FEF4-49CD-BC00-A2F107C86F03Q35115078-FC3325CF-E98F-4B52-AC75-66CE0D543F68Q35690002-ABA8F1A7-BAFB-45F3-B45E-B4356B18CA85Q35878982-742DC2F6-A0B5-4F53-8CD3-BB34AF635246Q35948262-45238DA3-2DD5-4AD1-B396-764D1DB005D9Q35960269-E4A9F00D-5370-432D-B286-B732042B5D0CQ36089061-57130251-5B6E-484F-9D8E-71C63CAFCC65Q36285233-3C28254A-CFBD-4F31-8470-3B146A3F7BFAQ36566606-C62CB486-6288-4806-B717-438CF288C90BQ36898587-EBEC4F20-10D5-41B6-927D-B5FDEBFDB517Q36900101-6C0819D3-EB02-40A6-BFD8-5A6737921532Q37114405-186749B7-E6C2-4945-ADC8-CFA75FEC72A7Q37124868-DE85B4D6-7119-476A-ACD9-753913614256Q37156645-1DD6960B-8AB2-4E32-83CE-3F7878029BAFQ37263603-BF0A774E-6CFE-44B9-AEEB-47680C972B8FQ37352730-ECCDC035-C2BD-4C21-A904-1D49CA98CBD0Q37412802-DA3DDEC8-D672-4B59-8D38-60A50341BF25Q37541482-538A4F8C-8F88-4E30-9659-0D85862F984AQ37622959-86718CF9-0D2F-44AC-98DA-912BED4BE539Q37887512-D9C6CA45-F490-4058-B545-776F96FF86A0Q38154164-CF217C21-9534-49EF-89AE-57AA213EECEBQ38679057-2C95B8A4-EEF3-4C4A-A765-1A40CADE1C62Q38835071-3FE0D4C0-B3DE-465D-9533-470571B438D3Q39077924-F7F7500A-C502-42ED-8C23-4604A974BD03Q40335405-E104A543-0189-400E-9A0F-9FE50E6C8040Q40611787-CDD9ECB9-0351-4C7E-8078-AEA474CDE374Q40705976-340F12C2-B864-4129-9006-5E0FA18D8639Q41088665-501C0F96-9B1A-48C6-A16C-4E7E01F51642Q41605423-926E3F8B-4A55-4811-A46D-4702F6F5C2E1Q41912237-060F8A6A-3037-46CB-B9E0-83A86B934430
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Candida biofilm: a well-designed protected environment.
@ast
Candida biofilm: a well-designed protected environment.
@en
type
label
Candida biofilm: a well-designed protected environment.
@ast
Candida biofilm: a well-designed protected environment.
@en
prefLabel
Candida biofilm: a well-designed protected environment.
@ast
Candida biofilm: a well-designed protected environment.
@en
P2093
P2860
P1433
P1476
Candida biofilm: a well-designed protected environment.
@en
P2093
Guangyin Zhou
Mahmoud A Ghannoum
Pranab K Mukherjee
Ryan Munyon
P2860
P304
P356
10.1080/13693780500107554
P577
2005-05-01T00:00:00Z